Privacy Concerns in Amazon and Aetna-CVS Health Deals: Q&A With a Cyberlaw Expert
ALM talked with Peter Swire, senior counsel at Alston & Bird and privacy and cybersecurity expert at the Georgia Institute of Technology's Scheller College of Business, about some of the legal and data privacy issues surrounding the new, data-driven health care delivery systems. These include the proposed merger between CVS Health and Aetna Inc., as well as the health initiative that Amazon.com, Berkshire Hathaway Inc. and JPMorgan Chase & Co. recently announced for its employees.
February 20, 2018 at 01:12 PM
7 minute read
Peter Swire.
Last December, CVS Health and Aetna Inc. announced plans to merge—combining one of the nation's largest health insurers with one of its biggest retail pharmacies. The companies' hope is to leverage the massive data pool that would be created by the deal, which currently is under review by the U.S. Department of Justice, to deliver more personalized and efficient health care.
And last month, Amazon.com announced that it would be teaming up with Berkshire Hathaway Inc. and JPMorgan Chase & Co. to create an independent health care company for the companies' employees. Around that same time, Amazon also posted a job listing for a professional experienced with the federal Health Insurance Portability and Accountability Act of 1996 (HIPAA) to work on health care-related compliance matters. And, in another consolidation believed to be linked to impending disruption by Amazon, the Albertsons Cos. Inc. supermarkets chain on Tuesday announced it would merge with drugstore chain Rite Aid Corp.
(A privacy rule enacted in 2000 set national privacy standards for protection of personally identifiable health information. HIPAA is enforced by the Office for Civil Rights at the Department of Health and Human Services.)
But anyone who has ever ordered a bottle of pain reliever or book about a particular disease from Amazon knows the e-commerce giant already has medical-related information about its users that may not be covered by HIPAA, leading to questions about how personal health information is collected, used and stored.
ALM talked with Peter Swire, senior counsel at Alston & Bird, former government official and privacy and cybersecurity expert at the Georgia Institute of Technology's Scheller College of Business, about some of the legal and data privacy issues surrounding these new, data-driven health care delivery systems. The interview has been edited for length and clarity.
How is HIPAA implicated in the proposed deal between CVS and Aetna?
Swire: Both [CVS and Aetna] are covered under HIPAA, but historically they were in two different categories of entities. So with the merger, the general rule is that the pharmacy data can be merged in the company's databases with the insurance data subject to minimal rules. HIPAA says you should only collect and share the minimum necessary data that's needed for the patient, but the rules there tend to be pretty flexible.
HIPAA also has rules about role-based access, because the janitors shouldn't see the psychiatric records. The role of someone for health insurance might require different data than the role that's needed for a health care provider. The merger doesn't give every health insurance employee the right to see all of the medical records from the pharmacy.
Does this type of regulation have an effect on CVS and Aetna's ability to implement this type of business model?
When they try to combine business operations, they'll have to go step by step and document why it's appropriate to share data with these new categories of recipients.
Are there other regulations that would govern the data?
The insurance companies are also regulated at the state level, so the rules for Aetna's data may be restricted by state insurance laws.
Similarly, states can apply stricter versions of the HIPAA rules, if they pass state laws to do that, and the pharmacy data would have to comply with those state law restrictions. For instance, some states have special rules for HIV patients, and the data for HIV medications would be subject to those stricter state rules.
What about the HIPAA issues with the Amazon-Berkshire Hathaway-JPMorgan Chase initiative?
For any new health insurance company owned by Amazon, all the HIPAA rules would apply to the insurance activities. For instance, they can't send insurance data out to third parties without patient consent or some special HIPAA exception.
And there are also marketing rules under HIPAA that set limits on how the covered entity can market to its customers. Those are quite complicated, so I don't have any view on what exactly Amazon health insurance could do with Amazon bookseller. But they would have to watch out for those HIPAA marketing rules.
What about health care information that could be derived from users' shopping history and patterns—for example, the fact that someone bought migraine medicine in bulk from Amazon?
That's another side of it. There are fewer legal restrictions on sending Amazon's e-commerce data to the health insurance company. Amazon can make a lot of inferences about its customers based on the health care books and searches that they do on the Amazon site. So Amazon might know that you have bought books about migraines and bought over-the-counter medicines for migraines, and that information is outside of HIPAA, typically, unless health insurance paid for the medicines. And that's true much more generally today. So all of those apps on people's phones—[including] fitness trackers and many other apps that can provide insight about a person's medical condition—are outside of HIPAA, unless they're being run by a covered entity.
Are there other regulations, state or federal, that would cover this type of data?
In general, the law hasn't caught up with all of this non-HIPAA collection of health data. So there are fewer restrictions on the e-commerce side of Amazon sending that data to the insurance side. The rules are stricter if the insurance side, which is a regulated covered entity that has to comply with HIPAA, tries to send data out to e-commerce.
Are there other issues implicated by the other two companies' involvement in the initiative?
JPMorgan Chase is the bank involved, and there's another set of issues that come up for financial services companies. The big privacy rule there is the Gramm-Leach-Bliley Act, which sets limits on taking banking information out of the financial services company and sending it to other companies. Bank customers have opt-out rights before data goes to a third party.
There's another issue that's less well-known: The bank regulators have issued rules limiting the use of medical information in financial decisions. So if JPMorgan Chase receives medical information, they have banking rules to follow about how they can or cannot use that medical information.
For practical purposes, there are medical privacy, financial privacy and e-commerce issues, and the overall structure has to comply with all of those different legal regimes.
Is there a reason for consumers to be concerned about such health care delivery systems that may center on data sharing?
Part of the reason for the HIPAA privacy rule was to reduce the chances that people would be treated worse because of their medical history. There are rules limiting what medical information employers can get before the hiring decision. There are rules against genetic discrimination, like the Genetic Information Nondiscrimination Act, which sets limits on decisions based on genetic information, and medical records can provide clues about a person's genetic history. So when these different types of databases are combined, there's a risk that decisions will occur that are less favorable to some of the individuals. And the privacy rules in part exist to protect against those uses of personal information.
This story has been updated with information about the Albertsons-Rite Aid merger.
Read more:
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllTrump's SEC Overhaul: What It Means for Big Law Capital Markets, Crypto Work
Financial Services Has a Trust Problem. Can GCs Help Right the Ship?
Covington, Steptoe Form New Groups Amid Demand in Regulatory, Enforcement Space
4 minute readDOJ Files Antitrust Suit Against Visa Alleging It Thwarts Payment-Processing Rivals
Trending Stories
- 1Stock Trading App Robinhood Hit With Privacy Class Action 1 Month After Alleged Data Breach
- 2NY High Court Returns Fired Priest's Discrimination Claim to State Agency
- 3Digging Deep to Mitigate Risk in Lithium Mine Venture Wins GM Legal Department of the Year Award
- 4Reminder: Court Rules and Statutes Apply to Pendente Lite Custody Decisions
- 5Consumer Cleared to Proceed With Claims Against CVS 'Non-Drowsy' Medication, Judge Says
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250